Elevance Health names Aimée Dailey president of government business in leadership shake-up

Reuters04-01
<a href="https://laohu8.com/S/ELV">Elevance Health</a> names Aimée Dailey president of government business in leadership shake-up
  • Elevance Health reshuffled senior leadership across Health Benefits, Carelon to sharpen execution, lift operating performance, support growth.
  • Aimée Dailey named president of Government Business, overseeing Medicare, Medicaid, Federal Government Solutions, Group Retiree Solutions.
  • Kristy Duffey appointed president of Carelon Health; nurse practitioner who most recently worked at Optum, CINQCARE.
  • Will Feest took on president of Carelon Insights alongside role as Carelon chief operating officer.
  • William Fleming joined as Carelon chief growth and strategy officer; former Humana executive focused on pharmacy, home health, care services innovation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevance Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603310900BIZWIRE_USPR_____20260330_BW766530) on March 31, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment